Payment overview · 2025
General Payments
$324.27
15 reported records · 6 companies
Healthcare provider profile · identity verified
Lucius M. Lampton, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · MAGNOLIA, MS · NPI 1689781007
Verified facts
What the public records show
CMS Open Payments records show Lucius M. Lampton, M.D. received $324.27 in general payments during 2025 across 15 reported records.
Otsuka America Pharmaceutical, Inc. accounted for 47.3% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 5 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Austedo Xr, Rexulti, Trelegy Ellipta.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported BRILINTA as an associated drug or biological on 993 records involving 512 distinct recipient NPIs. Public Medicare Part D data also shows 45 claims for Brilinta by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported FARXIGA as an associated drug or biological on 106133 records involving 42906 distinct recipient NPIs. Public Medicare Part D data also shows 122 claims for Farxiga by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LOKELMA as an associated drug or biological on 6897 records involving 4326 distinct recipient NPIs. Public Medicare Part D data also shows 21 claims for Lokelma by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYMBICORT as an associated drug or biological on 71 records involving 51 distinct recipient NPIs. Public Medicare Part D data also shows 43 claims for Symbicort by this doctor in 2024.
GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SHINGRIX as an associated drug or biological on 43515 records involving 26794 distinct recipient NPIs. Public Medicare Part D data also shows 13 claims for Shingrix by this doctor in 2024.
GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRELEGY ELLIPTA as an associated drug or biological on 131532 records involving 37148 distinct recipient NPIs. Public Medicare Part D data also shows 88 claims for Trelegy Ellipta by this doctor in 2024.
Lundbeck LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported REXULTI as an associated drug or biological on 71829 records involving 25812 distinct recipient NPIs. Public Medicare Part D data also shows 81 claims for Rexulti by this doctor in 2024.
Otsuka America Pharmaceutical, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported NUEDEXTA as an associated drug or biological on 393 records involving 285 distinct recipient NPIs. Public Medicare Part D data also shows 110 claims for Nuedexta by this doctor in 2024.
Otsuka America Pharmaceutical, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported REXULTI as an associated drug or biological on 160756 records involving 46288 distinct recipient NPIs. Public Medicare Part D data also shows 81 claims for Rexulti by this doctor in 2024.
Teva Pharmaceuticals USA, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported AUSTEDO XR as an associated drug or biological on 86263 records involving 23643 distinct recipient NPIs. Public Medicare Part D data also shows 16 claims for Austedo Xr by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | Unresolved — no canonical attribution shown | $153.44 | 47.3% | 6 | 2025 |
| GlaxoSmithKline, LLC. | Unresolved — no canonical attribution shown | $50.39 | 15.5% | 3 | 2025 |
| AstraZeneca Pharmaceuticals LP | Unresolved — no canonical attribution shown | $38.76 | 11.9% | 2 | 2025 |
| Lundbeck LLC | Unresolved — no canonical attribution shown | $36.70 | 11.3% | 2 | 2025 |
| Verona Pharma, Inc. | Unresolved — no canonical attribution shown | $26.32 | 8.1% | 1 | 2025 |
| Teva Pharmaceuticals USA, Inc. | Unresolved — no canonical attribution shown | $18.66 | 5.8% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $324.27 | 15 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| REXULTI Normalized: rexulti |
Drug | Lundbeck LLC, Otsuka America Pharmaceutical, Inc. | $190.14 | 8 | 2025 |
Source payment records
|
|||||
| TRELEGY ELLIPTA Normalized: trelegy ellipta |
Drug | GlaxoSmithKline, LLC. | $50.39 | 3 | 2025 |
Source payment records
|
|||||
| BREZTRI Normalized: breztri |
Drug | AstraZeneca Pharmaceuticals LP | $38.76 | 2 | 2025 |
Source payment records
|
|||||
| Ohtuvayre Normalized: ohtuvayre |
Drug | Verona Pharma, Inc. | $26.32 | 1 | 2025 |
Source payment records
|
|||||
| AUSTEDO XR Normalized: austedo xr |
Drug | Teva Pharmaceuticals USA, Inc. | $18.66 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| AUSTEDO XR austedo xr |
2025 | Austedo Xr | 2024 | 16 Beneficiary count suppressed |
exact normalized | Medicare Part D |
| REXULTI rexulti |
2025 | Rexulti | 2024 | 81 Beneficiary count suppressed |
exact normalized | Medicare Part D |
| TRELEGY ELLIPTA trelegy ellipta |
2025 | Trelegy Ellipta | 2024 | 88 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | BRILINTA open payments reported associated product |
CMS Open Payments — General Payments 993 supporting records · 512 recipient NPIs · example record 1206131430 |
Brilinta · 2024 Exact normalized brand match · 1 Part D row |
45 | suppressed by CMS |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | FARXIGA open payments reported associated product |
CMS Open Payments — General Payments 106133 supporting records · 42906 recipient NPIs · example record 1206131362 |
Farxiga · 2024 Exact normalized brand match · 1 Part D row |
122 | 16 |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | LOKELMA open payments reported associated product |
CMS Open Payments — General Payments 6897 supporting records · 4326 recipient NPIs · example record 1206131624 |
Lokelma · 2024 Exact normalized brand match · 1 Part D row |
21 | suppressed by CMS |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | SYMBICORT open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 51 recipient NPIs · example record 1206132610 |
Symbicort · 2024 Exact normalized brand match · 1 Part D row |
43 | 15 |
| GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference |
2025 | SHINGRIX open payments reported associated product |
CMS Open Payments — General Payments 43515 supporting records · 26794 recipient NPIs · example record 1190332452 |
Shingrix · 2024 Exact normalized brand match · 1 Part D row |
13 | suppressed by CMS |
| GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference |
2025 | TRELEGY ELLIPTA open payments reported associated product |
CMS Open Payments — General Payments 131532 supporting records · 37148 recipient NPIs · example record 1190332369 |
Trelegy Ellipta · 2024 Exact normalized brand match · 1 Part D row |
88 | 25 |
| Lundbeck LLC Exact reporting entity; no affiliate inference |
2025 | REXULTI open payments reported associated product |
CMS Open Payments — General Payments 71829 supporting records · 25812 recipient NPIs · example record 1251759986 |
Rexulti · 2024 Exact normalized brand match · 1 Part D row |
81 | suppressed by CMS |
| Otsuka America Pharmaceutical, Inc. Exact reporting entity; no affiliate inference |
2025 | NUEDEXTA open payments reported associated product |
CMS Open Payments — General Payments 393 supporting records · 285 recipient NPIs · example record 1227268901 |
Nuedexta · 2024 Exact normalized brand match · 1 Part D row |
110 | suppressed by CMS |
| Otsuka America Pharmaceutical, Inc. Exact reporting entity; no affiliate inference |
2025 | REXULTI open payments reported associated product |
CMS Open Payments — General Payments 160756 supporting records · 46288 recipient NPIs · example record 1227267708 |
Rexulti · 2024 Exact normalized brand match · 1 Part D row |
81 | suppressed by CMS |
| Teva Pharmaceuticals USA, Inc. Exact reporting entity; no affiliate inference |
2025 | AUSTEDO XR open payments reported associated product |
CMS Open Payments — General Payments 86263 supporting records · 23643 recipient NPIs · example record 1247244228 |
Austedo Xr · 2024 Exact normalized brand match · 1 Part D row |
16 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 2969 | 252 |
| Amlodipine Besylate | Amlodipine Besylate | 2027 | 197 |
| Levothyroxine Sodium | Levothyroxine Sodium | 1889 | 162 |
| Furosemide | Furosemide | 1804 | 189 |
| Pantoprazole Sodium | Pantoprazole Sodium | 1802 | 193 |
| Gabapentin | Gabapentin | 1739 | 183 |
| Trazodone Hcl | Trazodone Hcl | 1648 | 128 |
| Potassium Chloride | Potassium Chloride | 1576 | 153 |
| Sertraline Hcl | Sertraline Hcl | 1237 | 91 |
| Eliquis | Apixaban | 1227 | 98 |
| Buspirone Hcl | Buspirone Hcl | 1181 | 93 |
| Carvedilol | Carvedilol | 1133 | 98 |
| Tamsulosin Hcl | Tamsulosin Hcl | 1127 | 102 |
| Memantine Hcl | Memantine Hcl | 1036 | 81 |
| Metformin Hcl | Metformin Hcl | 1021 | 72 |
| Donepezil Hcl | Donepezil Hcl | 1018 | 86 |
| Clopidogrel | Clopidogrel Bisulfate | 990 | 91 |
| Metoprolol Tartrate | Metoprolol Tartrate | 986 | 88 |
| Mirtazapine | Mirtazapine | 940 | 74 |
| Quetiapine Fumarate | Quetiapine Fumarate | 915 | 73 |
| Losartan Potassium | Losartan Potassium | 842 | 114 |
| Famotidine | Famotidine | 820 | 67 |
| Escitalopram Oxalate | Escitalopram Oxalate | 776 | 58 |
| Lisinopril | Lisinopril | 761 | 60 |
| Omeprazole | Omeprazole | 744 | 108 |
| Duloxetine Hcl | Duloxetine Hcl | 638 | 63 |
| Levetiracetam | Levetiracetam | 636 | 49 |
| Hydralazine Hcl | Hydralazine Hcl | 595 | 56 |
| Baclofen | Baclofen | 536 | 36 |
| Jardiance | Empagliflozin | 533 | 46 |
| Metoprolol Succinate | Metoprolol Succinate | 518 | 60 |
| Xarelto | Rivaroxaban | 500 | 30 |
| Pravastatin Sodium | Pravastatin Sodium | 476 | 48 |
| Divalproex Sodium | Divalproex Sodium | 467 | 34 |
| Citalopram Hbr | Citalopram Hydrobromide | 463 | 32 |
| Montelukast Sodium | Montelukast Sodium | 463 | 46 |
| Meloxicam | Meloxicam | 460 | 44 |
| Fluoxetine Hcl | Fluoxetine Hcl | 427 | 46 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 412 | 42 |
| Spironolactone | Spironolactone | 392 | 43 |
| Myrbetriq | Mirabegron | 389 | 16 |
| Allopurinol | Allopurinol | 386 | 44 |
| Aripiprazole | Aripiprazole | 378 | 34 |
| Hydrochlorothiazide | Hydrochlorothiazide | 345 | 34 |
| Finasteride | Finasteride | 321 | 29 |
| Celecoxib | Celecoxib | 319 | 65 |
| Glipizide | Glipizide | 318 | 24 |
| Prednisone | Prednisone | 282 | 114 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 278 | 91 |
| Nifedipine Er | Nifedipine | 268 | 20 |
| Metformin Hcl Er | Metformin Hcl | 263 | 53 |
| Haloperidol | Haloperidol | 249 | 15 |
| Olanzapine | Olanzapine | 243 | 25 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 242 | 23 |
| Ropinirole Hcl | Ropinirole Hcl | 238 | 25 |
| Tizanidine Hcl | Tizanidine Hcl | 233 | 43 |
| Risperidone | Risperidone | 224 | 18 |
| Amiodarone Hcl | Amiodarone Hcl | 223 | 31 |
| Oxybutynin Chloride | Oxybutynin Chloride | 220 | 20 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 215 | 24 |
| Benztropine Mesylate | Benztropine Mesylate | 212 | 18 |
| Glimepiride | Glimepiride | 203 | 23 |
| Methimazole | Methimazole | 203 | suppressed |
| Buprenorphine-Naloxone | Buprenorphine Hcl/Naloxone Hcl | 201 | 22 |
| Simvastatin | Simvastatin | 197 | 23 |
| Sucralfate | Sucralfate | 193 | 23 |
| Chlorthalidone | Chlorthalidone | 189 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 180 | suppressed |
| Topiramate | Topiramate | 178 | 19 |
| Lamotrigine | Lamotrigine | 177 | 11 |
| Primidone | Primidone | 176 | 18 |
| Entresto | Sacubitril/Valsartan | 174 | 18 |
| Paroxetine Hcl | Paroxetine Hcl | 170 | 13 |
| Latanoprost | Latanoprost | 168 | 37 |
| Sevelamer Carbonate | Sevelamer Carbonate | 162 | 12 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 159 | 25 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 159 | 15 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 158 | 14 |
| Ondansetron Hcl | Ondansetron Hcl | 157 | 83 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 155 | 68 |
| Bupropion Xl | Bupropion Hcl | 151 | 14 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 145 | 40 |
| Pioglitazone Hcl | Pioglitazone Hcl | 144 | 23 |
| Propranolol Hcl | Propranolol Hcl | 144 | 27 |
| Fluticasone Propionate | Fluticasone Propionate | 143 | 58 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 141 | 17 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 134 | 16 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 133 | 104 |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 133 | 11 |
| Dicyclomine Hcl | Dicyclomine Hcl | 132 | 14 |
| Fenofibrate | Fenofibrate | 132 | suppressed |
| Atenolol | Atenolol | 130 | 11 |
| Pregabalin | Pregabalin | 127 | 37 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 124 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 122 | 16 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 121 | 13 |
| Valsartan | Valsartan | 121 | 11 |
| Azithromycin | Azithromycin | 120 | 95 |
| Clonidine Hcl | Clonidine Hcl | 119 | 38 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 117 | 24 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 115 | 46 |
| Benazepril Hcl | Benazepril Hcl | 114 | suppressed |
| Lorazepam | Lorazepam | 112 | 35 |
| Nuedexta | Dextromethorphan Hbr/Quinidine | 110 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 109 | 22 |
| Linzess | Linaclotide | 107 | 32 |
| Ranolazine Er | Ranolazine | 103 | suppressed |
| Tradjenta | Linagliptin | 101 | suppressed |
| Calcitriol | Calcitriol | 98 | suppressed |
| Ibuprofen | Ibuprofen | 97 | 25 |
| Doxycycline Hyclate | Doxycycline Hyclate | 96 | 35 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 94 | 73 |
| Oxcarbazepine | Oxcarbazepine | 93 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 91 | 20 |
| Novolog | Insulin Aspart | 91 | 32 |
| Ozempic | Semaglutide | 91 | 21 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 90 | 47 |
| Alprazolam | Alprazolam | 88 | 28 |
| Divalproex Sodium Er | Divalproex Sodium | 88 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 88 | suppressed |
| Fluconazole | Fluconazole | 88 | 50 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 88 | 25 |
| Zolpidem Tartrate | Zolpidem Tartrate | 88 | 26 |
| Insulin Aspart | Insulin Aspart | 87 | 40 |
| Midodrine Hcl | Midodrine Hcl | 84 | 17 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 81 | 24 |
| Rexulti | Brexpiprazole | 81 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 81 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 80 | suppressed |
| Colchicine | Colchicine | 76 | 11 |
| Ezetimibe | Ezetimibe | 76 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 75 | 14 |
| Fenofibrate | Fenofibrate Nanocrystallized | 74 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 72 | 34 |
| Ramipril | Ramipril | 70 | suppressed |
| Scopolamine | Scopolamine | 70 | 22 |
| Carbamazepine | Carbamazepine | 67 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 67 | 53 |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 67 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 67 | 14 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 66 | suppressed |
| Anastrozole | Anastrozole | 65 | suppressed |
| Insulin Lispro | Insulin Lispro | 65 | 23 |
| Levofloxacin | Levofloxacin | 64 | 53 |
| Haloperidol Lactate | Haloperidol Lactate | 63 | 23 |
| Namzaric | Memantine Hcl/Donepezil Hcl | 62 | suppressed |
| Nystatin | Nystatin | 60 | 29 |
| Bupropion Hcl Sr | Bupropion Hcl | 59 | 13 |
| Amantadine | Amantadine Hcl | 58 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 58 | 11 |
| Dutasteride | Dutasteride | 58 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 58 | 14 |
| Lovastatin | Lovastatin | 58 | suppressed |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 57 | 18 |
| Ceftriaxone | Ceftriaxone Sodium | 56 | 45 |
| Diclofenac Sodium | Diclofenac Sodium | 56 | 26 |
| Insulin Aspart Flexpen | Insulin Aspart | 56 | 19 |
| Lansoprazole | Lansoprazole | 56 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 56 | 22 |
| Warfarin Sodium | Warfarin Sodium | 56 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 55 | suppressed |
| Levemir | Insulin Detemir | 53 | 12 |
| Megestrol Acetate | Megestrol Acetate | 53 | 24 |
| Methocarbamol | Methocarbamol | 53 | 29 |
| Venlafaxine Hcl | Venlafaxine Hcl | 53 | suppressed |
| Nuplazid | Pimavanserin Tartrate | 52 | suppressed |
| Torsemide | Torsemide | 52 | suppressed |
| Tolterodine Tartrate | Tolterodine Tartrate | 51 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 50 | 39 |
| Tramadol Hcl | Tramadol Hcl | 50 | 28 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 50 | suppressed |
| Lubiprostone | Lubiprostone | 49 | suppressed |
| Metolazone | Metolazone | 49 | 11 |
| Ketoconazole | Ketoconazole | 48 | 12 |
| Lactulose | Lactulose | 48 | 19 |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 47 | suppressed |
| Clonazepam | Clonazepam | 47 | 18 |
| Glipizide Er | Glipizide | 47 | 12 |
| Creon | Lipase/Protease/Amylase | 46 | suppressed |
| Digoxin | Digoxin | 46 | 11 |
| Otezla | Apremilast | 46 | suppressed |
| Brilinta | Ticagrelor | 45 | suppressed |
| Novolog Flexpen | Insulin Aspart | 45 | 16 |
| Galantamine Hbr | Galantamine Hbr | 44 | suppressed |
| Gemfibrozil | Gemfibrozil | 44 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 44 | 13 |
| Irbesartan | Irbesartan | 44 | suppressed |
| Januvia | Sitagliptin Phosphate | 44 | suppressed |
| Mupirocin | Mupirocin | 43 | 30 |
| Symbicort | Budesonide/Formoterol Fumarate | 43 | 15 |
| Cephalexin | Cephalexin | 41 | 31 |
| Diltiazem 24hr Er | Diltiazem Hcl | 41 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 41 | suppressed |
| Novolin R | Insulin Regular, Human | 40 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 39 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 39 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 37 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 37 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 36 | 25 |
| Lurasidone Hcl | Lurasidone Hcl | 36 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl | 35 | 28 |
| Lidocaine Hcl | Lidocaine Hcl/Pf | 35 | 20 |
| Raloxifene Hcl | Raloxifene Hcl | 35 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 33 | suppressed |
| Naproxen | Naproxen | 33 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 32 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 31 | suppressed |
| Dexamethasone | Dexamethasone | 31 | 15 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 31 | suppressed |
| Nitroglycerin | Nitroglycerin | 31 | 20 |
| Albuterol Sulfate | Albuterol Sulfate | 30 | 20 |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 30 | 12 |
| Colesevelam Hcl | Colesevelam Hcl | 29 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 29 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 29 | 15 |
| Diltiazem Hcl | Diltiazem Hcl | 28 | suppressed |
| Fiasp | Insulin Aspart (Niacinamide) | 27 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 27 | 14 |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 26 | 12 |
| Fentanyl | Fentanyl | 26 | suppressed |
| Prezcobix | Darunavir/Cobicistat | 26 | suppressed |
| Zosyn | Piperacillin-Tazo-Dextrose,iso | 26 | suppressed |
| Ondansetron Odt | Ondansetron | 25 | 12 |
| Gentamicin Sulfate | Gentamicin Sulfate | 24 | 19 |
| Metoclopramide Hcl | Metoclopramide Hcl | 24 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 24 | suppressed |
| Rasagiline Mesylate | Rasagiline Mesylate | 24 | suppressed |
| Xifaxan | Rifaximin | 24 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 23 | suppressed |
| Clonidine | Clonidine | 23 | suppressed |
| Dexamethasone Sodium Phosphate | Dexamethasone Sodium Phosphate | 23 | 21 |
| Janumet | Sitagliptin Phos/Metformin Hcl | 23 | suppressed |
| Rybelsus | Semaglutide | 23 | suppressed |
| Estradiol | Estradiol | 22 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 22 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 22 | suppressed |
| Donepezil Hcl Odt | Donepezil Hcl | 21 | suppressed |
| Hydroxyurea | Hydroxyurea | 21 | suppressed |
| Levemir Flexpen | Insulin Detemir | 21 | suppressed |
| Lokelma | Sodium Zirconium Cyclosilicate | 21 | suppressed |
| Mounjaro | Tirzepatide | 21 | suppressed |
| Ofloxacin | Ofloxacin | 21 | 12 |
| Breyna | Budesonide/Formoterol Fumarate | 20 | suppressed |
| Methylprednisolone | Methylprednisolone | 20 | 18 |
| Movantik | Naloxegol Oxalate | 20 | suppressed |
| Temazepam | Temazepam | 20 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 20 | suppressed |
| Clozapine | Clozapine | 19 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 19 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 19 | suppressed |
| Suboxone | Buprenorphine Hcl/Naloxone Hcl | 19 | suppressed |
| Amoxicillin | Amoxicillin | 18 | 15 |
| Enulose | Lactulose | 18 | suppressed |
| Hydrocortisone | Hydrocortisone | 18 | suppressed |
| Neomycin-Polymyxin-Dexameth | Neomycin/Polymyxin B/Dexametha | 18 | 11 |
| Nystop | Nystatin | 18 | 11 |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 18 | 17 |
| Calcium Acetate | Calcium Acetate | 17 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 17 | suppressed |
| Gemtesa | Vibegron | 17 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 17 | 13 |
| Verapamil Er | Verapamil Hcl | 17 | suppressed |
| Austedo Xr | Deutetrabenazine | 16 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 16 | suppressed |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 16 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 16 | suppressed |
| Atropine Sulfate | Atropine Sulfate | 15 | suppressed |
| Biktarvy | Bictegrav/Emtricit/Tenofov Ala | 15 | suppressed |
| Glycopyrrolate | Glycopyrrolate | 15 | suppressed |
| Glyxambi | Empagliflozin/Linagliptin | 15 | suppressed |
| Linezolid | Linezolid | 15 | 13 |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 15 | suppressed |
| Telmisartan | Telmisartan | 15 | suppressed |
| Valproic Acid | Valproic Acid | 15 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 14 | suppressed |
| Erythromycin | Erythromycin Base | 14 | suppressed |
| Glyburide-Metformin Hcl | Glyburide/Metformin Hcl | 14 | suppressed |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 14 | 11 |
| Liothyronine Sodium | Liothyronine Sodium | 14 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 14 | 11 |
| Semglee (Yfgn) Pen | Insulin Glargine-Yfgn | 14 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 14 | suppressed |
| Alphagan P | Brimonidine Tartrate | 13 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 13 | suppressed |
| Cyclosporine | Cyclosporine | 13 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 13 | suppressed |
| Olanzapine Odt | Olanzapine | 13 | suppressed |
| Phenytoin | Phenytoin | 13 | suppressed |
| Quetiapine Fumarate Er | Quetiapine Fumarate | 13 | suppressed |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 13 | suppressed |
| Sps | Sodium Polystyrene Sulfon/Sorb | 13 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 13 | suppressed |
| Trulicity | Dulaglutide | 13 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 13 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 12 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 12 | suppressed |
| Ceftriaxone | Ceftriaxone In Is-Osm Dextrose | 12 | suppressed |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 12 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 12 | suppressed |
| Metronidazole | Metronidazole | 12 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 12 | suppressed |
| Probenecid | Probenecid | 12 | suppressed |
| Vancomycin Hcl | Vancomycin/Water For Inj (Peg) | 12 | suppressed |
| Asenapine Maleate | Asenapine Maleate | 11 | suppressed |
| Aspirin-Dipyridamole Er | Aspirin/Dipyridamole | 11 | suppressed |
| Cefdinir | Cefdinir | 11 | suppressed |
| Combigan | Brimonidine Tartrate/Timolol | 11 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 11 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 11 | suppressed |
| Ertapenem | Ertapenem Sodium | 11 | suppressed |
| Humulin R | Insulin Regular, Human | 11 | suppressed |
| Invega Sustenna | Paliperidone Palmitate | 11 | suppressed |
| Juluca | Dolutegravir/Rilpivirine | 11 | suppressed |
| Rivastigmine | Rivastigmine | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $324.27 · 15 records | Otsuka America Pharmaceutical, Inc. | AUSTEDO XR, BREZTRI, Ohtuvayre, REXULTI, TRELEGY ELLIPTA | 10 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Austedo Xr play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with AstraZeneca Pharmaceuticals LP?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error